Identification of Cardiovascular Risk Factors Linked to Renal Failure Progression

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-07-31

Study Completion Date

2011-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to appreciate the influence of renal failure progression on vasculopathy (coronary calcifications and left ventricular hypertrophy) and cardiovascular risk factors.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

New Biomarkers of Bone Mineral Metabolism as Cardiovascular Risk Factors in Chronic Kidney Disease Patients

NCT02808572

Chronic Kidney Disease

RECRUITING NA

Factors Influencing Risk of Progression of Chronic Kidney Disease

NCT03954470

Chronic Kidney Disease stage4

COMPLETED

Cohort Follow-up: Progression and Consequences of Chronic Kidney Disease.

NCT04070885

Chronic Renal Diseases Renal Function Disorder

COMPLETED

Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients

NCT01427374

End Stage Renal Disease

TERMINATED

Evaluation of a Multidisciplinary Care Pathway on the Evolution of Renal Function in Patients With Advanced Chronic Kidney Disease

NCT06495385

Chronic Kidney Disease stage4 Chronic Kidney Disease Stage 5

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is to appreciate the relationship between:

* extension of coronary calcifications and chronic renal failure progression
* extension of coronary calcifications and levels of osteoprotegerin (bone disease marker)
* cardiovascular risk factors and coronary calcifications
* cardiovascular risk factors and existence of cardiovascular diseases

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Renal Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient who has signed the written consent form
* Patient aged \> 18 and \< 90 years
* Chronic renal failure defined by glomerular filtration rate (GFR)

* group 1: GFR \>90 mL/min with urinary biological abnormalities and GFR comprised between 90 and 60 mL/min
* group 2: GFR comprised between 60 and 30 mL/min
* group 3: GFR \<30 mL/min but without dialysis therapy